A spine-zapping implant helped 3 people with a muscle-wasting disease
walk better
Send a link to a friend
[February 05, 2025]
By LAURAN NEERGAARD
WASHINGTON (AP) — Three people with a muscle-destroying disease destined
to worsen got a little stronger – able to stand and walk more easily –
when an implanted device zapped their spinal cord.
On Wednesday, researchers reported what they called the first evidence
that a spine-stimulating implant already being tested for paralysis
might also aid neurodegenerative diseases like spinal muscle atrophy –
by restoring some muscle function, at least temporarily.
“These people were definitely not expecting an improvement,” said Marco
Capogrosso, an assistant professor at the University of Pittsburgh who
led the research. Yet over the month-long pilot study, “they were
getting better and better.”
Spinal muscle atrophy or SMA is a genetic disease that gradually
destroys motor neurons, nerve cells in the spinal cord that control
muscles. That leads muscles to waste away, especially in the legs, hips
and shoulders and sometimes those involved with breathing and
swallowing. There is no cure. A gene therapy can save the lives of very
young children with a severe form of the disease, and there are some
medicines to slow worsening in older patients.
Stimulating the spinal cord with low levels of electricity has long been
used to treat chronic pain but Capogrosso’s team also has tested it to
help people paralyzed from strokes or spinal cord injury move their
limbs unaided. While turned on, it zaps circuits of dormant nerves
downstream of the injury to activate muscles.

Then Capogrosso wondered if that same technology might help SMA in a
similar way — by revving up related sensory nerves so they wake up
damaged muscle cells, helping them move to combat wasting.
The Pitt researchers implanted electrodes over the lower spinal cord of
three adults with SMA and tested their muscle strength, fatigue, range
of motion and changes in gait and walking distance when the device was
firing and when it was turned off.
It didn’t restore normal movement but with just a few hours of spinal
stimulation a week, all quickly saw improvements in muscle strength and
function, researchers reported in the journal Nature Medicine.
[to top of second column]
|

This image from video provided by UPMC and University of Pittsburgh
Health Sciences shows Doug McCullough, who has spinal muscular
atrophy, during tests of experimental spinal cord stimulation to
improve muscle function in Pittsburgh, on March 14, 2023. (UPMC,
University of Pittsburgh Health Sciences via AP)
 “With a progressive disease you
never get any better,” said study participant Doug McCullough, 57,
of Franklin Park, New Jersey. “Either you’re staying stable or
getting worse. So having any improvement is just a really surreal
and very exciting benefit.”
All three participants significantly increased how far they could
walk in six minutes, and one who initially couldn’t stand from a
kneeling position could by the study’s end, Capogrosso said. And
McCullough’s gait changed so that each step was about three times
longer.
“They get less fatigued so they can walk for longer,” Capogrosso
said. “Even a person this many years into the disease can improve.”
Intriguingly, researchers found the improvements didn’t disappear as
soon as the stimulator was switched off, though they did fade as
participants were tracked after the study ended.
McCullough said even when the stimulator was turned off, some nights
his legs “would just feel supercharged.”
While he understood that the device had to be removed at the study’s
end, he was disappointed. He said there were some lingering benefits
at his six-week checkup, but none after six months.
Neuroscientist Susan Harkema, who led pioneering studies of
stimulation for spinal cord injuries while at the University of
Louisville, cautioned the new study is small and short but called it
an important proof of concept. She said it’s logical to test the
technique against a list of muscle-degenerating diseases.
“Human spinal circuitry is very sophisticated – it’s not just a
bunch of reflexes controlled by the brain,” said Harkema, now with
the Kessler Foundation, a rehabilitation research nonprofit. “This
is a very solid study, an important contribution to move forward.”
At Pitt, Capogrosso said some small but longer studies are getting
underway.
All contents © copyright 2025 Associated Press. All rights reserved |